Aquilo Capital Management, LLC Spero Therapeutics, Inc. Transaction History

Aquilo Capital Management, LLC

$128 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $1.3 Million - $4.22 Million	-1,918,021 Reduced 36.04%	3,403,210 $6.81 Million
Q2 2022 Aug 15, 2022	BUY	$0.74 - $7.44 $29,397 - $295,568	39,727 Added 0.75%	5,321,231 $3.94 Million
Q1 2022 May 16, 2022	BUY	$7.87 - $15.15 $2.5 Million - $4.81 Million	317,323 Added 6.39%	5,281,504 $45.9 Million
Q4 2021 Feb 14, 2022	BUY	$13.09 - $18.77 $5.24 Million - $7.52 Million	400,493 Added 8.78%	4,964,181 $79.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $9.57 Million - $14.3 Million	734,479 Added 19.18%	4,563,688 $84 Million
Q1 2021 May 17, 2021	SELL	$13.23 - $21.48 $1.36 Million - $2.21 Million	-103,000 Reduced 2.62%	3,829,209 $56.4 Million
Q4 2020 Feb 16, 2021	SELL	$11.65 - $22.07 $6.58 Million - $12.5 Million	-564,933 Reduced 12.56%	3,932,209 $76.2 Million
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $22.9 Million - $36.1 Million	2,554,061 Added 131.44%	4,497,142 $50.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $908,321 - $1.77 Million	124,941 Added 6.87%	1,943,081 $26.3 Million
Q1 2020 May 15, 2020	BUY	$5.27 - $10.41 $3.5 Million - $6.91 Million	663,784 Added 57.5%	1,818,140 $14.7 Million
Q2 2019 Aug 14, 2019	BUY	$10.25 - $14.36 $1.03 Million - $1.44 Million	100,000 Added 9.48%	1,154,356 $13.3 Million
Q1 2019 May 15, 2019	BUY	$6.26 - $13.31 $140,280 - $298,263	22,409 Added 2.17%	1,054,356 $13.5 Million
Q4 2018 Feb 14, 2019	BUY	$5.69 - $11.28 $1.32 Million - $2.62 Million	232,256 Added 29.04%	1,031,947 $6.35 Million
Q3 2018 Nov 14, 2018	BUY	$9.69 - $17.79 $3.71 Million - $6.81 Million	383,000 Added 91.91%	799,691 $8.41 Million
Q2 2018 Aug 14, 2018	BUY	$10.41 - $17.85 $4.34 Million - $7.44 Million	416,691 New	416,691 $6.11 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.56 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.68 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.29 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$1.02 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$925,920
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Account